Lenalid Lenalidomide 15mg

Lenalid 15mg capsule is prescribed for the treatment of various conditions, including multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma. Specifically, lenalid 15mg is recommended to manage a subtype of a myelodysplastic syndrome called deletion 5q MDS, which involves the loss of a segment of chromosome 5. The active ingredient in Lenalid 15mg capsule, lenalidomide, functions by supporting the body's immune system and targeting cancer cells directly. It hampers the multiplication of malignant cells, inhibits the growth of blood vessels associated with cancer, and prompts the immune system to attack cancer cells. Lenalid works by exterminating abnormal cells in the bone marrow and restoring the production of normal blood cells.